Extracellular DNA in blood has emerged as a minimally invasive biomarker for detecting disease. Apart from sequencing cell-free DNA fragments, researchers can also obtain information about methylation states and expression patterns. Scientists combine these data to understand the pathogenic processes that lead to DNA shedding and to develop biomarkers that can predict diseases before patients develop symptoms. In this webinar brought to you by The Scientist, Stella Goulopoulou and Iwijn de Vlaminck will discuss how they analyze cell-free DNA to identify biomarkers of different diseases and their complications.
Topics to be covered
Circulating mitochondrial DNA dynamics in preeclampsia
Cell-free biomarkers to predict immune-related complications of COVID-19, organ transplants, and stem cell therapies
Tuesday, June 7, 2022
3:00 - 4:30 PM Eastern Time
This webinar will also be available on-demand.
Meet the speakers
Styliani (Stella) Goulopoulou,PhD Associate Professor of Physiology Physiology Division Lawrence D. Longo, MD Center for Perinatal Biology Loma Linda University, Loma Linda, California
Iwijn De Vlaminck, PhD Associate Professor Nancy E. and Peter C. Meinig School of Biomedical Engineering Cornell University
Sponsored by
Register
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
